Gert Hoogland

Gerardus Hoogland is a medical professional with a proven record for building strong, growth-oriented phrama and healthcare businesses

His over 30 years of experience spans the research, marketing, entrepreneurial, and operational aspects, of these sectors.Gert began his career as a research fellow at the Amsterdam University and moved on to hold several roles in the pharmaceutical sector. His key achievements include boosting the market share of Schering, New Zealand, as their CEO. He was also the CEO of the company’s South African operations and managed their pharmaceutical and agrochemical divisions. He founded two businesses in South Africa, which represented international pharma brands in the country. One of them, Pharmaplan Pty Ltd, got acquired by the Johannesburg Stock Exchange listed Litha Healthcare Group. He served as the Executive Director and Board Member of Lithia Healthcare Ltd and expanded the business to encompass the full spectrum of pharma products from OTCs to orphan drugs. Under his leadership, the company’s sales grew to about USD 75 million. Gerardus is currently the Chief Executive Officer at HealthCrest AG, a Switzerland-based investment and consulting company. He also serves on the board of several enterprises, such as the CBMG (China Bio Med Group listed on Nasdaq OTC), and Allcare AG (a Zurich-based primary care group practice). He graduated as a Doctor from the Amsterdam University and also studied law at the Erasmus University, Holland. He has an MBA from INSEAD, France.